Clinical Trial Update: 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3, 3-week randomized trial comparing asenapine, olanzapine, and placebo for the treatment of bipolar mania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Saphris (asenapine)
• Zyprexa (olanzapine)

Snippet

Sponsor: Organon and Co | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED